Given the established pathological role of TNFα in different diseases, we aimed at investigating whether SVZ-derived aNPCs are able to revert the effects of this cytokine also in cortical neurons, which represent the main target cells for neurodegenerative processes such as those occurring in Alzheimer’s disease. The gene discussed is TNF; the disease is Alzheimer disease.